CollPlant Biotechnologies has appointed Dr. Ruti Ben Shlomi, CEO and Co-Founder of LightSolver, to its Board of Directors following its acquisition of LightSolver. This move strengthens CollPlant's position in photonic computing, leveraging LightSolver's Laser Processing Unit technology to accelerate high-performance computing applications. Dr. Ben Shlomi brings deep expertise in physics and entrepreneurship, aiding CollPlant's transition from technology validation to commercialization. The acquisition also diversifies CollPlant's portfolio beyond biotech into advanced computing sectors like aerospace and defense.
Procter & Gamble remains a well-managed company but its stock is currently overvalued at 21.15 times its fiscal year 2027 earnings per share, with expected growth of only 1.3%. The company's dividend yield of 2.95% is less attractive compared to risk...
CLPS Incorporation announced it has regained compliance with Nasdaq's minimum bid price rule after its stock price remained at or above $1.00 per share for 10 consecutive trading days from August 20 to September 2, 2026. This means CLPS is now fully ...
Ramaco Resources announced that the negative trading activity in its Class A common stock on September 3, 2026, was likely due to Yorktown Energy Partners distributing about one million shares to its limited partners. Yorktown is one of Ramaco's larg...
Alexandria Real Estate Equities, a leading life science real estate company, marked Blood Cancer Awareness Month by spotlighting its investments and tenants developing treatments for blood cancers like leukemia and lymphoma. The company emphasized it...
Cellebrite DI Ltd., a leader in AI-driven digital investigative solutions, announced participation in two investor events in September 2026. The company will hold one-on-one meetings at the Lake Street Best Ideas Growth Conference on September 10 and...
